| Drug Name | XALKORI ( Crizotinib ) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Patient Card
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Hepatotoxicity Pneumonitis/Interstitial lung disease, QTc Prolongation Bradycardia, Vision disorder, Renal cyst, Oedema, Leukopenia Neuropathy, Gastrointestinal Perforation,Reproductive Toxicity (including pregnant and lactating women |
| patient guide |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|